Type 2 Diabetes: A New Path Awaits
The SOTA studies are evaluating an investigational oral tablet that may help manage your blood glucose levels.
Diet, exercise and education are important in the management of Type 2 Diabetes (T2D), but many people also require drug therapy to manage their
This investigational oral tablet when combined with diet and exercise may help manage blood glucose levels in people with T2D. Additionally, the knowledge gained from this study may help other people with T2D in the future.
You may be eligible to participate in the SOTA-GLIM study if you:
- Are diagnosed with Type 2 Diabetes
- Are 18 years of age or older
- Have HbA1c levels between 7-10%
- Are currently being treated with Metformin
Explore A New Opportunity! To find out if you qualify, contact: Clinical Trials at (405) 271-3604 ext. 46896 or firstname.lastname@example.org
A 52-week Randomized, Double-blind, Double-dummy, Active and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin compared to Glimepiride or Placebo Added to Metformin in Patients with Type 2 Diabetes who have Inadequate Glycemic Control with Metformin Monotherapy
Jonea Lim, MD, Principal Investigator
The University of Oklahoma is an equal opportunity institution.
IRB #8693 | IRB APPROVAL DATE: 05/02/2018